BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Breaking News: New research identifies EBV antigen targets for MS therapies
Breaking News: New research identifies EBV antigen targets for MS therapies
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Amylin, Lilly and Alkermes reply to FDA's complete response letter on Bydureon
April 23, 2010
Nuon advances NU-1618 to phase IIb for chronic hyperuricemia in gout
April 23, 2010
Dainippon Sumitomo set to launch Metgluco in Japan
April 23, 2010
Lipocine earns milestone payment from Abbott for oral testosterone product
April 23, 2010
Merck & Co. presents new CETP inhibitor prodrugs for hypercholesterolemia
April 23, 2010
Dutogliptin reduces HbA1c in phase III trial in type 2 diabetes
April 22, 2010
Medvir discovers novel selective cathepsin K inhibitors
April 22, 2010
Hygeia Therapeutics to advance development of topical hormone receptor modulators
April 20, 2010
Studies on progesterone caproate for prevention of preterm birth
April 19, 2010
Merck & Co.'s new GPR119 agonist lowers blood glucose in murine diabetes model
April 19, 2010
Previous
1
2
…
701
702
703
704
705
706
707
708
709
…
1800
1801
Next
RSS